Freda Lewis-Hall - 18 Nov 2024 Form 4 Insider Report for CONDUIT PHARMACEUTICALS INC. (CDT)

Role
Director
Signature
/s/ Freda Lewis-Hall
Issuer symbol
CDT
Transactions as of
18 Nov 2024
Net transactions value
+$40,250
Form type
4
Filing time
20 Nov 2024, 16:30:11 UTC
Previous filing
17 May 2024
Next filing
20 Dec 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDT Common Stock Award $40,250 +437,976 $0.0919 437,976 18 Nov 2024 Direct F1
holding CDT Common Stock 2,003,324 18 Nov 2024 See Footnote F2
holding CDT Common Stock 516,987 18 Nov 2024 See Footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares issued in lieu of $40,250 accrued in cash retainers under the Issuer's Non-Employee Director Compensation Program.
F2 The shares are held of record by Intelmed LLC ("Intelmed"). Ms. Lewis-Hall is the Managing Director of Intelmed and in such capacity has voting and investment discretion with respect to the Shares held of record by Intelmed. By virtue of this relationship, Ms. Lewis-Hall may be deemed to share beneficial ownership of the shares held of record by Intelmed. Ms. Lewis-Hall disclaims any such beneficial ownership except to the extent of her pecuniary interest therein.
F3 The shares are held by Ms. Lewis-Hall's spouse, Mr. Emerson Hall, Jr. As Mr. Hall's spouse and by virtue of their relationship, Ms. Lewis-Hall may be deemed to share beneficial ownership of such shares held by record by Mr. Emerson Hall, Jr. Ms. Lewis-Hall disclaims any such beneficial ownership except to the extent of her pecuniary interest therein.